- Article
Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget’s Disease of Bone with PFN1 Mutation Are Treatable by Alendronate
- Zhu Ling,
- Hailati Aini,
- Shuhei Kajikawa,
- Jumpei Shirakawa,
- Kunikazu Tsuji,
- Yoshinori Asou,
- Hideyuki Koga,
- Ichiro Sekiya,
- Akira Nifuji and
- Yoichi Ezura
- + 1 author
A novel osteolytic disorder due to PFN1 mutation was discovered recently as early-onset Paget’s disease of bone (PDB). Bone loss and pain in adult PDB patients have been treated using bisphosphonates. However, therapeutic strategies for this sp...